Pharmosa Biopharm Inc. (TPEX:6875)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
52.20
+0.90 (1.75%)
Apr 2, 2025, 1:30 PM CST

Pharmosa Biopharm Ratios and Metrics

Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2018 - 2019
Period Ending
Apr '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2018 - 2019
Market Capitalization
6,7386,82910,3147,055--
Upgrade
Market Cap Growth
-33.79%-33.79%46.18%---
Upgrade
Enterprise Value
5,2375,3389,3306,778--
Upgrade
Last Close Price
52.2052.9088.0062.22--
Upgrade
PE Ratio
--1219.72---
Upgrade
PS Ratio
39.3840.7532.80---
Upgrade
PB Ratio
3.483.529.079.27--
Upgrade
P/TBV Ratio
3.533.539.079.27--
Upgrade
P/OCF Ratio
-327.98---
Upgrade
EV/Sales Ratio
31.2631.8629.67---
Upgrade
EV/EBITDA Ratio
-3121.44---
Upgrade
Debt / Equity Ratio
0.060.060.130.030.070.31
Upgrade
Debt / EBITDA Ratio
--7.04---
Upgrade
Asset Turnover
0.100.100.30---
Upgrade
Inventory Turnover
1.741.74----
Upgrade
Quick Ratio
14.0314.0312.5824.2313.964.18
Upgrade
Current Ratio
14.4814.4813.0224.6514.394.31
Upgrade
Return on Equity (ROE)
-10.84%-10.84%0.89%-41.24%-54.73%-103.22%
Upgrade
Return on Assets (ROA)
-7.81%-7.81%-0.17%-24.49%-28.67%-35.08%
Upgrade
Return on Capital (ROIC)
-8.19%-8.19%-0.17%-25.13%-29.48%-36.52%
Upgrade
Earnings Yield
-2.47%-2.44%0.08%-3.78%--
Upgrade
FCF Yield
-4.34%-4.28%-0.48%-3.81%--
Upgrade
Buyback Yield / Dilution
-11.49%-11.49%-15.09%-16.02%-78.34%-27.94%
Upgrade
Source: S&P Global Market Intelligence. Standard template. Financial Sources.